Back to top

vaccines: Archive

Sundeep Ganoria

MRNA Stock Soars 143% in a Month: Time to Buy, Hold or Sell?

Moderna stock surges 143% in a month on positive cancer therapy results, but competition and valuation raise key questions for investors.

MRNANegative Net Change PFENegative Net Change MRKNegative Net Change BNTXNegative Net Change

Sundeep Ganoria

Does Moderna's mRNA Flu Shot Face a New Challenge From GSK?

MRNA's newly approved mFlusiva faces a potential challenge as GSK advances an mRNA flu vaccine targeting two viral proteins.

MRNANegative Net Change SNYNegative Net Change GSKNegative Net Change MRKNegative Net Change

Zacks Equity Research

Healthcare ETFs to Watch Post Merck-Moderna Cancer Vaccine Breakthrough

Merck-Moderna's melanoma vaccine success could boost immunotherapy growth, putting healthcare ETFs in the spotlight.

MRKNegative Net Change MRNANegative Net Change XBINegative Net Change PPHNegative Net Change IDNANegative Net Change CANCNegative Net Change BMYNegative Net Change